Comparison of benefit between dabigatran and warfarin among patients with atrial fibrillation: A systematic review

Amal K Sulieman

Open source

DOI: 10.4103/2045-080x.181039
Published: 2016
Container: Archives of Pharmacy Practice
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 4 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4103/2045-080x.181039,
  title = {Comparison of benefit between dabigatran and warfarin among patients with atrial fibrillation: A systematic review},
  author = {Amal K Sulieman},
  year = {2016},
  journal = {Archives of Pharmacy Practice},
  doi = {10.4103/2045-080x.181039},
  url = {https://doi.org/10.4103/2045-080x.181039}
}

RIS

TY  - JOUR
TI  - Comparison of benefit between dabigatran and warfarin among patients with atrial fibrillation: A systematic review
AU  - Amal K Sulieman
PY  - 2016
JO  - Archives of Pharmacy Practice
DO  - 10.4103/2045-080x.181039
UR  - https://doi.org/10.4103/2045-080x.181039
ER  -

APA

Sulieman, A. K. (2016). Comparison of benefit between dabigatran and warfarin among patients with atrial fibrillation: A systematic review. Archives of Pharmacy Practice. https://doi.org/10.4103/2045-080x.181039

Source records

doaj · retrieved 2026-09-26T04:14:18.113Z